tiprankstipranks
Trending News
More News >
CAMP4 Therapeutics Corporation (CAMP)
NASDAQ:CAMP
US Market

CAMP4 Therapeutics Corporation (CAMP) Financial Statements

Compare
121 Followers

CAMP4 Therapeutics Corporation Financial Overview

CAMP4 Therapeutics Corporation's market cap is currently $207.52M. The company's EPS TTM is $-0.55; its P/E ratio is -1.58; CAMP4 Therapeutics Corporation is scheduled to report earnings on November 20, 2025, and the estimated EPS forecast is $-0.30. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 652.00K$ 350.00K$ 0.00$ 295.84M$ 308.59M
Gross Profit$ 652.00K$ 350.00K$ 0.00$ 121.89M$ 122.41M
Operating Income$ -53.09M$ -51.88M$ -45.00M$ -15.31M$ -3.87M
EBITDA$ -51.39M$ -50.20M$ -44.12M$ 7.49M$ 18.13M
Net Income$ -51.79M$ -49.29M$ -44.19M$ -31.15M$ -21.16M
Balance Sheet
Cash & Short-Term Investments$ 64.04M$ 38.38M$ 83.19M$ 91.11M$ 91.69M
Total Assets$ 78.31M$ 54.95M$ 102.55M$ 402.29M$ 441.82M
Total Debt$ 8.65M$ 11.69M$ 12.39M$ 209.17M$ 210.80M
Net Debt$ -55.39M$ -26.69M$ -70.80M$ 118.05M$ 119.11M
Total Liabilities$ 15.16M$ 178.68M$ 180.08M$ 322.11M$ 342.50M
Stockholders' Equity$ 63.14M$ -123.73M$ -77.53M$ 80.18M$ 99.32M
Cash Flow
Free Cash Flow$ -46.00M$ -44.83M$ -42.57M$ -17.52M$ 17.23M
Operating Cash Flow$ -45.56M$ -44.16M$ -38.54M$ -4.22M$ 28.59M
Investing Cash Flow$ -441.00K$ -678.00K$ -4.03M$ -7.58M$ -13.69M
Financing Cash Flow$ 71.66M$ 301.00K$ 100.16M$ -2.64M$ -27.32M
Currency in USD

CAMP4 Therapeutics Corporation Earnings and Revenue History

CAMP4 Therapeutics Corporation Debt to Assets

CAMP4 Therapeutics Corporation Cash Flow

CAMP4 Therapeutics Corporation Forecast EPS vs Actual EPS